| Experienced stigmatization reduced quality of life of patients with a neuromuscular disease: a cross-sectional study KM van der Beek, I Bos, B Middel, K Wynia Clinical rehabilitation 27 (11), 1029-1038, 2013 | 46 | 2013 |
| Validation of the ICF core set for neuromuscular diseases I Bos, HA Stallinga, B Middel, JBM Kuks, K Wynia Eur J Phys Rehabil Med 49 (2), 179-87, 2013 | 31 | 2013 |
| The prevalence and severity of disease-related disabilities and their impact on quality of life in neuromuscular diseases I Bos, K Wynia, J Almansa, G Drost, B Kremer, J Kuks Disability and rehabilitation 41 (14), 1676-1681, 2019 | 26 | 2019 |
| Development and testing psychometric properties of an ICF-based health measure: The Neuromuscular Disease Impact Profile. I Bos, JBM Kuks, K Wynia Journal of rehabilitation medicine 47 (5), 445-453, 2015 | 21 | 2015 |
| The ambiguity of the concept of participation in measurement instruments: Operationalization of participation influences research outcomes HA Stallinga, PU Dijkstra, I Bos, YF Heerkens, PF Roodbol Clinical Rehabilitation 28 (12), 1225-1236, 2014 | 21 | 2014 |
| The extremity function index (EFI), a disability severity measure for neuromuscular diseases: psychometric evaluation I Bos, K Wynia, G Drost, J Almansa, JBM Kuks Disability and Rehabilitation 40 (13), 1561-1568, 2018 | 4 | 2018 |
| Stability and relative validity of the Neuromuscular Disease Impact Profile (NMDIP) I Bos, JBM Kuks, J Almansa, HPH Kremer, K Wynia BMC neurology 17, 1-8, 2017 | 1 | 2017 |
| The impact of neuromuscular diseases on functioning and quality of life I Bos | | 2018 |
| Dossier klinisch-2. ICF-instrumenten voor continuïteit van zorg. F Hellema, J Kinds, M Boelens, I Bos, ML Luttik, G Stallinga, G Tijssen, ... TvZ Tijdschrift voor Verpleegkundigen 10, 55-59, 2002 | | 2002 |
Klaske WyniaUniversitair Medisch Centrum Groningen, Universiteit van GroningenVerified email at umcg.nl
Klaske WyniaUniversitair Medisch Centrum Groningen, Universiteit van GroningenVerified email at umcg.nl